Ampe shareholder alert: jakubowitz law reminds ampio shareholders of a lead plaintiff deadline of october 17, 2022

New york , oct. 7, 2022 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of ampio pharmaceuticals, inc. (nyse: ampe). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/ampio-pharmaceuticals-inc-loss-submission-form/?id=32439&from=4 this lawsuit is on behalf of all persons or entities that purchased or otherwise acquired ampio common stock between december 29, 2020 and august 3, 2022, inclusive.
AMPE Ratings Summary
AMPE Quant Ranking